NEW YORK (GenomeWeb News) – Clinical Data has completed the sale of its Cogenics division to Beckman Coulter for $17 million, the firm announced after the close of the market on Tuesday.

At closing, Beckman paid $15.4 million in cash, with $2.5 million held in escrow for 18 months. Clinical Data retained around $2.2 million in cash from Cogenics immediately prior to the sale, which resulted in net cash proceeds of $14.9 million.